Rolapitant approved for chemotherapy-induced nausea and vomiting.

Subjects

Subjects :

Drug Approval
Humans
Neoplasms complications
Neoplasms drug therapy
United States
United States Food and Drug Administration
Antiemetics therapeutic use
Antineoplastic Agents adverse effects
Nausea chemically induced
Nausea drug therapy
Spiro Compounds therapeutic use
Vomiting chemically induced
Vomiting drug therapy

Details

Language :

English

ISSN :

1535-2900

Volume :

72

Issue :

21

Database :

MEDLINE

Journal :

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Publication Type :

Periodical

Accession number :

26490812

Full Text :

https://doi.org/10.2146/news150071